Molecular Determinants of the Response of Tumor Cells to Boswellic Acids

• Main Authors: Thomas Efferth, Henry Johannes Greten, Tolga Eichhorn
• Format: Article
• Language: English
• Published: MDPI AG 2011-08-01
• Series: Pharmaceuticals
• Subjects: apoptosis; Boswellia; ceramide; frankincense; natural products; olibanum; pharmacogenomics; sphingomyelin
• Online Access: http://www.mdpi.com/1424-8247/4/8/1171/

Frankincense (Boswellia serrata, B. carterii) is used as traditional remedy to treat inflammatory diseases. The molecular effects of the active ingredients, the boswellic acids, on the immune system have previously been studied and verified in several clinical studies. Boswellic acids also inhibit cancer cell growth in vitro and in vivo. The molecular basis of the cytotoxicity of boswellic acids is, however, not fully understood as yet. By mRNA-based microarray, COMPARE, and hierarchical cluster analyses, we identified a panel of genes from diverse functional groups, which were significantly associated with sensitivity or resistance of a- or b-boswellic acids, such as transcription factors, signal transducers, growth regulating genes, genes involved in RNA and protein metabolism and others. This indicates that boswellic acids exert profound cytotoxicity on cancer cells by a multiplicity of molecular mechanisms.